$2.39 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$5.17 - $17.25The lowest and highst price in the last 52 weeks.
0.0xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$2.39 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+25.1%|
|Outstanding Shares||298 Million|
|Avg 30 Day Volume||4.91 Million|
|Earnings per Share||$0.00|
|Price to Sales Ratio||-|
|Price to Book Ratio||-|
|Revenue to Enterprise Value||-|
|EBIT to Enterprise Value||-|
|Total Debt to Enterprise Value||-|
|Debt to Equity||-|
|Quarterly Earnings Growth (YoY)||-|
|Return on Equity||-|
|Return on Assets||-|
|Return on Invested Capital||-|
SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the H.C. Wainwright 23...Intrado Digital Media, 5 days ago
Regarding the trend, note that the strongest trend exists on the 20 day timeframe. The post Sorrento Therapeutics Inc (SRNE): Price Down $-0.01 (-0.19)% Over Past Day, Down $-0.02 (-0.27)% Over Pas...ETF Daily News, 8 days ago
Adoptive T cell Therapy, otherwise called cell immunotherapy, is a type of therapy that utilizes the phones of our resistant framework to wipe out malignant growth. A portion of these methodologies...OpenPR, 10 days ago